Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Development of a new model of Parkinson´s disease

ABSTRACT: Development of a new model of Parkinson´s disease

PROVIDER: PRJNA1018840 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26110200_1.fastq.gz	Fastqsanger.gz
	SRR26110200_2.fastq.gz	Fastqsanger.gz
	SRR26110201_1.fastq.gz	Fastqsanger.gz
	SRR26110201_2.fastq.gz	Fastqsanger.gz
	SRR26110202_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Development of a new model of Parkinson´s disease

Project description:To get insight the molecular mechanism underlying neuronal loss in Parkinson´s disease. We performed gene expression profiling analysis using data obtained from RNA-seq of midbrain of mice injected with an AAV control or an AAV expressing human tyrosinase that induces neuromelanin accumulation and subsequent neuronal loss.

2025-03-09 | GSE243520 | GEO

Parkinson Disease Frontal Cortex ncRNA Profiling

Project description:Parkinson Disease Frontal Cortex ncRNA Profiling

| PRJNA659521 | ENA

Parkinson Disease Frontal Cortex Transcriptomic analysis

Project description:Parkinson Disease Frontal Cortex Transcriptomic analysis

| PRJNA659523 | ENA

Innate and Adaptive Immunity in Parkinson Disease

Project description:Innate and Adaptive Immunity in Parkinson Disease

| PRJNA646548 | ENA

Innate and Adaptive Immunity in Parkinson Disease

Project description:Innate and Adaptive Immunity in Parkinson Disease

| PRJNA646549 | ENA

Rescuing voluntary motor behavior in a Parkinson´s disease model by aCRISPR mediated reprogramming of striatal astrocytes into induced GABAergic neurons

Project description:Cell replacement strategies of affected cells have been performed in clinical studies of Parkinson´s disease with variable outcome. Conversion of endogenous glial cells into functional neurons might represent a more reliable alternative, thus here we developed a knock-in mouse line carrying a dual dCas9 transactivator system (dCAM), which allowed the conditional activation of the endogenous genes Ascl1, Lmx1a, and Nr4a2 in striatal astrocytes in vivo by delivering sgRNAs specific for their endogenous loci. In order to move this successful approach toward translation, we established an AAV based activator system carrying intein-split-dCas9-VP64, SAM (AAV-dCAS) activators, and the specific sgRNAs targeting transcription factor combinations. Both systems, the dCAM and the AAV-dCAS approach were successful in reprogramming of striatal astrocytes into GABAergic neurons, which functionally integrate into striatal circuits as evidenced by the alleviation of specific motor behaviors in a 6-OHDA Parkinson’s disease model. Thus, the AAV-dCAS approach may enable clinical therapies for Parkinson´s disease by reprogramming striatal astrocytes.

2022-03-15 | GSE149872 | GEO

Parkinson Disease Frontal Cortex Transcriptomic analysis

Project description:We analyzed the transcriptome of the Frontal Cortex (FC) of Parkinson diseased (PD) individuals compared to age-matched controls.

2024-09-03 | GSE156928 | GEO

Palmitome analysis in parkinson´s disease

Project description:Proteomic analysis of the cortical palmitome derived from parkinson´s disease and control subjects

2023-10-13 | PXD037352 | JPOST Repository

Investigation in the cannabigerol derivative VCE-003.2 as a disease- modifying agent in a mouse model of experimental synucleinopathy

Project description:Here we explore the striatum transcriptomic effects of alpha-synuclein administration in mice as model of Parkinson´s disease. Moreover, we also explore the neuroprotective effect of cannabonoid-based druga (VCE-003.2) as a potential neuroportective agent in Parkinson´s disease

2024-11-30 | E-MTAB-13768 | biostudies-arrayexpress

Parkinson Disease Frontal Cortex ncRNA Profiling

Project description:We aimed to profile the expression of the entire population of annotated lncRNAs (GENCODE 15) in the Frontal Cortex (FC) of Parkinson diseased (PD) individuals compared to age-matched controls.

2024-09-03 | GSE156926 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data